Evaluation of myocardial contraction fraction in transcatheter aortic valve replacement
Evaluation of myocardial contraction fraction in transcatheter aortic valve replacement
dc.contributor.author | Machado, Luana da Graça | |
dc.contributor.author | Salgado, Angelo | |
dc.contributor.author | Lorenzo, Andrea de | |
dc.date.accessioned | 2025-02-07T14:02:25Z | |
dc.date.available | 2025-02-07T14:02:25Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Objective: Myocardial contraction fraction (MCF), a costless, easy-to-perform echocardiographic measure, which estimates cardiac function through the volumetric measurement of myocardial shortening, may be a useful prognostic indicator in patients undergoing transcatheter aortic valve replacement (TAVR). This study aimed to evaluate MCF in patients who underwent TAVR at a public hospital in Rio de Janeiro, Brazil. Methods: This was a retrospective cohort study. Clinical and echocardiographic data were obtained from medical records. MCF was calculated as FDV in mL/FSV in mL x100, where FDV= final diastolic volume and FSV= final systolic volume. These were derived from the dimensions of the left ventricle. The FDV was estimated as 4.5 x (final diastolic diameter of the left ventricle) and the FSV was estimated as 3.72 x (final systolic diameter of the left ventricle). Patients were followed for 66 months, and all-cause mortality was registered. Results: Overall, 78 patients were studied. Median age was 78 years. Mortality was 56.4% over 9 years, with 29% of deaths in the first year. Pre-TAVR median MCF (45.9%) was low, while mean left ventricular ejection fraction (LVEF) was normal (57.0%). In patients who survived after the procedure, MCF increased post-TAVR, but in those who died, it decreased (49.3% vs 45.1%). Conclusions: MCF may demonstrate left ventricular dysfunction unrecognized by LVEF measurement in patients undergoing TAVR, and may be a prognostic marker in this patient population. | |
dc.identifier.citation | Machado LG, Salgado A, Lorenzo A. Evaluation of myocardial contraction fraction in transcatheter aortic valve replacement. Heart, Vessels and Transplantation. 2024;8(1):5. doi: 10.24969/hvt.2023.449. | |
dc.identifier.other | DOI: 10.24969/hvt.2023.449 | |
dc.identifier.uri | https://dspace.inc.saude.gov.br/handle/123456789/819 | |
dc.language.iso | en | |
dc.publisher | Heart, Vessels and Transplantation | |
dc.subject | Transcatheter aortic valve replacement | en |
dc.subject | aortic stenosis | en |
dc.subject | myocardial contraction fraction | en |
dc.subject | ventricular function. | en |
dc.title | Evaluation of myocardial contraction fraction in transcatheter aortic valve replacement | |
dc.type | Article |